We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity.
- Authors
Farooq, Mudassir; Usman, Faisal; Zaib, Sumera; Shah, Hamid Saeed; Jamil, Qazi Adnan; Akbar Sheikh, Fatima; Khan, Ajmal; Rabea, Sameh; Hagras, Soheir A. A.; El-Saber Batiha, Gaber; Khan, Imtiaz
- Abstract
Voriconazole (VRC) is a broad-spectrum antifungal agent belonging to BCS class II (biopharmaceutical classification system). Despite many efforts to enhance its solubility, this primary issue still remains challenging for formulation scientists. Transethosomes (TELs) are one of the potential innovative nano-carriers for improving the solubility and permeation of poorly soluble and permeable drugs. We herein report voriconazole-loaded transethosomes (VRCT) fabricated by the cold method and followed by their incorporation into carbopol 940 as a gel. The prepared VRCT were evaluated for % yield, % entrapment efficiency (EE), surface morphology, possible chemical interaction, particle size, zeta potential, and polydispersity index (PDI). The optimized formulation had a particle size of 228.2 nm, a zeta potential of −26.5 mV, and a PDI of 0.45 with enhanced % EE. Rheology, spreadability, extrudability, in vitro release, skin permeation, molecular docking, antifungal, and antileishmanial activity were also assessed for VRCT and VRC loaded transethosomal gel (VTEG). Ex-vivo permeation using rat skin depicted a transdermal flux of 22.8 µg/cm2/h with enhanced efficiency up to 4-fold. A two-fold reduction in inhibitory as well as fungicidal concentration was observed against various fungal strains by VRCT and VTEG besides similar results against L-donovani. The development of transethosomal formulation can serve as an efficient drug delivery system through a topical route with enhanced efficacy and better patient compliance.
- Subjects
ANTIFUNGAL agents; SKIN permeability; VORICONAZOLE; DRUG delivery systems; ZETA potential; PATIENT compliance; SURFACE morphology
- Publication
Molecules, 2022, Vol 27, Issue 10, p3347
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules27103347